iRadimed Corporation (IRMD) News

Form ARS - Annual Report to Security Holders

Form EFFECT - Notice of Effectiveness

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]

IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share

Reports record revenue of $17.6 million for the first quarter of 2024.Reports GAAP diluted EPS of $0.32 and...

IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd

WINTER SPRINGS, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today...

IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference

WINTER SPRINGS, Fla., March 13, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD...

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

Form 8-K - Current report

IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results

Reports record revenue of $17.5 million for the fourth quarter and $65.6 million for the full year of 2023...

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.

WINTER SPRINGS, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today...

IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 Revenue

Reports preliminary fourth quarter 2023 revenue of $17.5 million WINTER SPRINGS, Fla., Jan. 09, 2024 (GLOBE...